Filter News
Area of Research
News Topics
- (-) Net Zero (1)
- (-) Neutron Science (5)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (1)
- Artificial Intelligence (3)
- Big Data (1)
- Bioenergy (9)
- Biology (18)
- Biomedical (6)
- Biotechnology (5)
- Buildings (2)
- Chemical Sciences (10)
- Climate Change (7)
- Composites (4)
- Computer Science (7)
- Coronavirus (7)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (7)
- Environment (16)
- Fusion (1)
- Grid (1)
- High-Performance Computing (5)
- Isotopes (3)
- Machine Learning (2)
- Materials (12)
- Materials Science (9)
- Microscopy (4)
- Molten Salt (1)
- Nanotechnology (6)
- National Security (2)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (1)
- Polymers (5)
- Quantum Science (1)
- Security (2)
- Simulation (4)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (6)
- Transformational Challenge Reactor (1)
- Transportation (4)
Media Contacts
In a discovery aimed at accelerating the development of process-advantaged crops for jet biofuels, scientists at ORNL developed a capability to insert multiple genes into plants in a single step.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
ASM International recently elected three researchers from ORNL as 2021 fellows. Selected were Beth Armstrong and Govindarajan Muralidharan, both from ORNL’s Material Sciences and Technology Division, and Andrew Payzant from the Neutron Scattering Division.
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.